Victory Capital Management Inc. Cuts Stock Position in McKesson Corporation $MCK

Victory Capital Management Inc. trimmed its position in McKesson Corporation (NYSE:MCK) by 12.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 229,534 shares of the company’s stock after selling 32,762 shares during the period. Victory Capital Management Inc.’s holdings in McKesson were worth $177,324,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. GGM Financials LLC purchased a new stake in shares of McKesson in the third quarter valued at about $25,000. State of Wyoming acquired a new stake in McKesson in the second quarter valued at about $29,000. Hopwood Financial Services Inc. acquired a new stake in McKesson in the third quarter valued at about $31,000. Abound Wealth Management increased its position in McKesson by 104.3% during the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after purchasing an additional 24 shares during the period. Finally, Delos Wealth Advisors LLC purchased a new position in shares of McKesson during the 2nd quarter worth approximately $35,000. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Trading Up 0.4%

Shares of NYSE MCK opened at $995.05 on Wednesday. The company’s 50-day moving average price is $875.61 and its 200 day moving average price is $812.05. McKesson Corporation has a 52 week low of $621.88 and a 52 week high of $999.00. The stock has a market cap of $121.88 billion, a price-to-earnings ratio of 28.62, a PEG ratio of 1.59 and a beta of 0.38.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, research analysts expect that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s payout ratio is 9.43%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the company. TD Cowen lifted their price target on McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Wells Fargo & Company upped their price target on shares of McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 5th. Evercore reiterated an “outperform” rating and issued a $1,000.00 price objective on shares of McKesson in a research note on Thursday, November 6th. Morgan Stanley restated an “overweight” rating and set a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Finally, Weiss Ratings downgraded shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, February 5th. Thirteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $943.50.

Insider Buying and Selling

In other news, EVP Leann B. Smith sold 190 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the transaction, the executive vice president owned 2,989 shares of the company’s stock, valued at $2,824,605. The trade was a 5.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Thomas L. Rodgers sold 276 shares of the company’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the transaction, the executive vice president directly owned 2,268 shares in the company, valued at $1,851,096.24. The trade was a 10.85% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 1,143 shares of company stock worth $1,046,070 in the last ninety days. 0.08% of the stock is currently owned by insiders.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.